Obesity And Diabetes Mellitus Typ 2 clinical trials

Explore recruiting obesity and diabetes mellitus typ 2 clinical trials.

Recruiting obesity and diabetes mellitus typ 2 studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Obesity And Diabetes Mellitus Typ 2 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Investigation of pharmacokinetics, safety and tolerability of a single subcutaneous dose of NNC0487-0111 in participants with various degrees of renal impairment and normal renal function.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Obesity And Diabetes Mellitus Typ 2 trials by city

Obesity And Diabetes Mellitus Typ 2 in Toronto Obesity And Diabetes Mellitus Typ 2 in Vancouver Obesity And Diabetes Mellitus Typ 2 in Montreal Obesity And Diabetes Mellitus Typ 2 in Calgary Obesity And Diabetes Mellitus Typ 2 in Edmonton Obesity And Diabetes Mellitus Typ 2 in Ottawa Obesity And Diabetes Mellitus Typ 2 in Winnipeg Obesity And Diabetes Mellitus Typ 2 in Quebec City Obesity And Diabetes Mellitus Typ 2 in Hamilton Obesity And Diabetes Mellitus Typ 2 in Kitchener Obesity And Diabetes Mellitus Typ 2 in London Obesity And Diabetes Mellitus Typ 2 in Halifax Obesity And Diabetes Mellitus Typ 2 in New York Obesity And Diabetes Mellitus Typ 2 in Los Angeles Obesity And Diabetes Mellitus Typ 2 in Chicago Obesity And Diabetes Mellitus Typ 2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease